Literature DB >> 23605472

Hypoxia increases serum amyloid A3 (SAA3) in differentiated 3T3-L1 adipocytes.

Edson Mendes de Oliveira1, Silvana Sandri, Franciele Hinterholz Knebel, Caroline Garcia Iglesias Contesini, Ana Campa, Fabíola Branco Filippin-Monteiro.   

Abstract

Hypoxia has been implicated as a possible cause of adipose tissue inflammation. Furthermore, the acute phase protein serum amyloid A (SAA) has been associated with the modulation of the adipogenic process, and it is well-known that obese individuals have increased levels of SAA. The effect of hypoxia in the expression and production of SAA was examined in murine 3T3-L1 adipocytes. Hypoxia leads to a substantial increase in SAA3 mRNA and protein level, apparently in a time-dependent manner (threefold in 48 h), in fully differentiated 3T3-L1, followed by reestablishment of gene expression to basal levels after 24 h of reoxygenation. Hypoxia-induced SAA may be one of the key molecules to the development of the inflammatory response in adipose tissue.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23605472     DOI: 10.1007/s10753-013-9644-9

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  17 in total

Review 1.  Inflammation and metabolic disorders.

Authors:  Gökhan S Hotamisligil
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

2.  Acute serum amyloid A induces migration, angiogenesis, and inflammation in synovial cells in vitro and in a human rheumatoid arthritis/SCID mouse chimera model.

Authors:  Mary Connolly; Alessandra Marrelli; Mark Blades; Jennifer McCormick; Paola Maderna; Catherine Godson; Ronan Mullan; Oliver FitzGerald; Barry Bresnihan; Costantino Pitzalis; Douglas J Veale; Ursula Fearon
Journal:  J Immunol       Date:  2010-04-30       Impact factor: 5.422

3.  A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 by human blood neutrophil.

Authors:  C J Furlaneto; A Campa
Journal:  Biochem Biophys Res Commun       Date:  2000-02-16       Impact factor: 3.575

4.  The adipokine SAA3 is induced by interleukin-1beta in mouse adipocytes.

Authors:  Grit Sommer; Sebastian Weise; Susan Kralisch; Philipp E Scherer; Ulrike Lössner; Matthias Blüher; Michael Stumvoll; Mathias Fasshauer
Journal:  J Cell Biochem       Date:  2008-08-15       Impact factor: 4.429

5.  Serum amyloid A attenuates cellular insulin sensitivity by increasing JNK activity in 3T3-L1 adipocytes.

Authors:  X Y Ye; Y M Xue; J P Sha; C Z Li; Z J Zhen
Journal:  J Endocrinol Invest       Date:  2009-03-26       Impact factor: 4.256

6.  Is serum amyloid A an endogenous TLR4 agonist?

Authors:  Silvana Sandri; Dunia Rodriguez; Eliane Gomes; Hugo Pequeno Monteiro; Momtchilo Russo; Ana Campa
Journal:  J Leukoc Biol       Date:  2008-02-05       Impact factor: 4.962

7.  Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes.

Authors:  Bohan Wang; I Stuart Wood; Paul Trayhurn
Journal:  Pflugers Arch       Date:  2007-07-03       Impact factor: 3.657

8.  The acute phase protein Serum Amyloid A induces lipolysis and inflammation in human adipocytes through distinct pathways.

Authors:  Aurélie Faty; Pascal Ferré; Stéphane Commans
Journal:  PLoS One       Date:  2012-04-19       Impact factor: 3.240

9.  Hypoxia decreases insulin signaling pathways in adipocytes.

Authors:  Claire Regazzetti; Pascal Peraldi; Thierry Grémeaux; Rosanna Najem-Lendom; Issam Ben-Sahra; Mireille Cormont; Frédéric Bost; Yannick Le Marchand-Brustel; Jean-François Tanti; Sophie Giorgetti-Peraldi
Journal:  Diabetes       Date:  2008-11-04       Impact factor: 9.461

10.  Regulation of serum amyloid A3 (SAA3) in mouse colonic epithelium and adipose tissue by the intestinal microbiota.

Authors:  Christopher S Reigstad; Gunnel Ostergren Lundén; Jenny Felin; Fredrik Bäckhed
Journal:  PLoS One       Date:  2009-06-09       Impact factor: 3.240

View more
  7 in total

1.  Protein profiling of isolated uterine AA amyloidosis causing fetal death in goats.

Authors:  Patricia M Gaffney; Bradd Barr; Joan D Rowe; Cyrus Bett; Ioannis Drygiannakis; Federico Giannitti; Margarita Trejo; Majid Ghassemian; Patrice Martin; Eliezer Masliah; Christina J Sigurdson
Journal:  FASEB J       Date:  2014-11-24       Impact factor: 5.191

2.  Serum amyloid A1 is upregulated in human glioblastoma.

Authors:  Franciele Hinterholz Knebel; Miyuki Uno; Thais F Galatro; Luziane Potrich Bellé; Sueli Mieko Oba-Shinjo; Suely Kazue N Marie; Ana Campa
Journal:  J Neurooncol       Date:  2017-03-11       Impact factor: 4.130

3.  Serum amyloid A links endotoxaemia to weight gain and insulin resistance in mice.

Authors:  Edson M de Oliveira; Thais P Ascar; Jacqueline C Silva; Silvana Sandri; Silene Migliorini; Ricardo A Fock; Ana Campa
Journal:  Diabetologia       Date:  2016-04-28       Impact factor: 10.122

Review 4.  Serum amyloid A1: Structure, function and gene polymorphism.

Authors:  Lei Sun; Richard D Ye
Journal:  Gene       Date:  2016-03-03       Impact factor: 3.688

5.  Serum amyloid A in the placenta and its role in trophoblast invasion.

Authors:  Silvana Sandri; Alexandre Urban Borbely; Isabella Fernandes; Edson Mendes de Oliveira; Franciele Hinterholz Knebel; Rodrigo Ruano; Marcelo Zugaib; Fabiola Filippin-Monteiro; Estela Bevilacqua; Ana Campa
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

6.  Serum Amyloid A Production Is Triggered by Sleep Deprivation in Mice and Humans: Is That the Link between Sleep Loss and Associated Comorbidities?

Authors:  Edson M de Oliveira; Bruna Visniauskas; Sergio Tufik; Monica L Andersen; Jair R Chagas; Ana Campa
Journal:  Nutrients       Date:  2017-03-21       Impact factor: 5.717

7.  Acute Inflammation Is a Predisposing Factor for Weight Gain and Insulin Resistance.

Authors:  Edson Mendes de Oliveira; Jacqueline C Silva; Thais P Ascar; Silvana Sandri; Alexandre F Marchi; Silene Migliorini; Helder T I Nakaya; Ricardo A Fock; Ana Campa
Journal:  Pharmaceutics       Date:  2022-03-11       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.